Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Marzouka NA"'
Autor:
Marzouka NA; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Eriksson P; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Bernardo C; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Hurst CD; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's, St James's University Hospital, Leeds, United Kingdom., Knowles MA; Division of Molecular Medicine, Leeds Institute of Medical Research at St James's, St James's University Hospital, Leeds, United Kingdom., Sjödahl G; Urology-Urothelial Cancer, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden., Liedberg F; Urology-Urothelial Cancer, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden., Höglund M; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. Electronic address: mattias.hoglund@med.lu.se.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2022 Sep; Vol. 24 (9), pp. 992-1008. Date of Electronic Publication: 2022 Jul 16.
Autor:
Sjödahl G; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden. Electronic address: gottfrid.sjodahl@med.lu.se., Abrahamsson J; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden., Holmsten K; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Oncology, Capio S:t Göran Hospital, Stockholm, Sweden., Bernardo C; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Chebil G; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Eriksson P; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Johansson I; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Kollberg P; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden., Lindh C; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Lövgren K; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Marzouka NA; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Olsson H; Department of Pathology, Department of Clinical and Experimental Medicine, Medical Faculty, Linköping University, Linköping, Sweden., Höglund M; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Ullén A; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Pelvic Cancer, Genitourinary Oncology and Urology unit, Karolinska University Hospital, Stockholm, Sweden., Liedberg F; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden.
Publikováno v:
European urology [Eur Urol] 2022 May; Vol. 81 (5), pp. 523-532. Date of Electronic Publication: 2021 Nov 13.
Autor:
Bernardo C; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Scheelevägen 2, 223 81 Lund, Sweden. Electronic address: carina.bernardo@med.lu.se., Eriksson P; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Scheelevägen 2, 223 81 Lund, Sweden. Electronic address: pontus.eriksson@med.lu.se., Marzouka NA; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Scheelevägen 2, 223 81 Lund, Sweden. Electronic address: nour-al-dain.marzouka@med.lu.se., Liedberg F; Division of Urological Research, Department of Translational Medicine, Lund University, Skåne University Hospital, Jan Waldenströms Gata 5, 20502 Malmö, Sweden. Electronic address: fredrik.liedberg@med.lu.se., Sjödahl G; Division of Urological Research, Department of Translational Medicine, Lund University, Skåne University Hospital, Jan Waldenströms Gata 5, 20502 Malmö, Sweden. Electronic address: gottfrid.sjodahl@med.lu.se., Höglund M; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Scheelevägen 2, 223 81 Lund, Sweden. Electronic address: mattias.hoglund@med.lu.se.
Publikováno v:
Human pathology [Hum Pathol] 2022 Apr; Vol. 122, pp. 11-24. Date of Electronic Publication: 2022 Jan 31.
Autor:
Sjödahl G; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden. Electronic address: gottfrid.sjodahl@med.lu.se., Abrahamsson J; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden., Holmsten K; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Oncology, Capio S:t Göran Hospital, Stockholm, Sweden., Bernardo C; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Eriksson P; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Kollberg P; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden., Marzouka NA; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Höglund M; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Ullén A; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Pelvic Cancer, Genitourinary Oncology and Urology Unit, Karolinska University Hospital, Stockholm, Sweden., Liedberg F; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden.
Publikováno v:
European urology [Eur Urol] 2022 Apr; Vol. 81 (4), pp. e92-e93. Date of Electronic Publication: 2022 Jan 14.
Autor:
Eriksson P; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Marzouka NA; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Sjödahl G; Urology - urothelial cancer, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden., Bernardo C; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Liedberg F; Urology - urothelial cancer, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden., Höglund M; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Publikováno v:
Bioinformatics (Oxford, England) [Bioinformatics] 2022 Jan 27; Vol. 38 (4), pp. 1022-1029.
Autor:
Marzouka NA; Department of Clinical Sciences, Division of Oncology, Lund University, 22381 Lund, Sweden., Eriksson P; Department of Clinical Sciences, Division of Oncology, Lund University, 22381 Lund, Sweden.
Publikováno v:
Bioinformatics (Oxford, England) [Bioinformatics] 2021 Sep 29; Vol. 37 (18), pp. 3043-3044.
Recurring urothelial carcinomas show genomic rearrangements incompatible with a direct relationship.
Autor:
Marzouka NA; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Lindgren D; Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden., Eriksson P; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Sjödahl G; Division of Urological Research, Department of Translational Medicine, Malmö University Hospital, Malmö, Sweden., Bernardo C; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Liedberg F; Division of Urological Research, Department of Translational Medicine, Malmö University Hospital, Malmö, Sweden.; Department of Urology, Skåne University Hospital, Malmö, Sweden., Axelson H; Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden., Höglund M; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden. mattias.hoglund@med.lu.se.
Publikováno v:
Scientific reports [Sci Rep] 2020 Nov 11; Vol. 10 (1), pp. 19539. Date of Electronic Publication: 2020 Nov 11.
Autor:
Sjödahl G; Department of Translational Medicine, Division of Urological Research, Lund University, Lund, Sweden.; Department of Urology, Skåne University Hospital, Skåne, Sweden., Eriksson P; Division of Oncology and Pathology, Clinical Sciences, Lund University, Lund, Sweden., Patschan O; Department of Translational Medicine, Division of Urological Research, Lund University, Lund, Sweden.; Department of Urology, Skåne University Hospital, Skåne, Sweden., Marzouka NA; Division of Oncology and Pathology, Clinical Sciences, Lund University, Lund, Sweden., Jakobsson L; Division of Oncology and Pathology, Clinical Sciences, Lund University, Lund, Sweden., Bernardo C; Division of Oncology and Pathology, Clinical Sciences, Lund University, Lund, Sweden., Lövgren K; Division of Oncology and Pathology, Clinical Sciences, Lund University, Lund, Sweden., Chebil G; Division of Oncology and Pathology, Clinical Sciences, Lund University, Lund, Sweden., Zwarthoff E; Department of Pathology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, The Netherlands., Liedberg F; Department of Translational Medicine, Division of Urological Research, Lund University, Lund, Sweden.; Department of Urology, Skåne University Hospital, Skåne, Sweden., Höglund M; Division of Oncology and Pathology, Clinical Sciences, Lund University, Lund, Sweden.
Publikováno v:
International journal of cancer [Int J Cancer] 2020 May 01; Vol. 146 (9), pp. 2636-2647. Date of Electronic Publication: 2019 Nov 14.
Autor:
Bernardo C; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden., Eriksson P; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden., Marzouka NA; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden., Liedberg F; Division of Urological Research, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden., Sjödahl G; Division of Urological Research, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden., Höglund M; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Publikováno v:
The Journal of pathology [J Pathol] 2019 Nov; Vol. 249 (3), pp. 308-318. Date of Electronic Publication: 2019 Aug 27.
Autor:
Bocci M; Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Medicon Village, Building 404:A3, 223 81, Lund, Sweden., Sjölund J; Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Medicon Village, Building 404:A3, 223 81, Lund, Sweden., Kurzejamska E; Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Medicon Village, Building 404:A3, 223 81, Lund, Sweden., Lindgren D; Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Medicon Village, Building 404:A3, 223 81, Lund, Sweden., Marzouka NA; Unit of Urothelial Cancer Genomics, Department of Oncology and Pathology, Lund University, Scheelevägen 8, 22363, Lund, Sweden., Bartoschek M; Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Medicon Village, Building 404:A3, 223 81, Lund, Sweden., Höglund M; Unit of Urothelial Cancer Genomics, Department of Oncology and Pathology, Lund University, Scheelevägen 8, 22363, Lund, Sweden., Pietras K; Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Medicon Village, Building 404:A3, 223 81, Lund, Sweden. kristian.pietras@med.lu.se.
Publikováno v:
Angiogenesis [Angiogenesis] 2019 Feb; Vol. 22 (1), pp. 117-131. Date of Electronic Publication: 2018 Aug 21.